These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31532533)

  • 41. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
    Sun MF; Shen YQ
    Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Altered Microbiome in Patients With Cirrhosis and Complications.
    Acharya C; Bajaj JS
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):307-321. PubMed ID: 30099098
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human microbiome restoration and safety.
    Daliri EB; Tango CN; Lee BH; Oh DH
    Int J Med Microbiol; 2018 Jul; 308(5):487-497. PubMed ID: 29773467
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Microbiome in Crohn's Disease: Role in Pathogenesis and Role of Microbiome Replacement Therapies.
    Khanna S; Raffals LE
    Gastroenterol Clin North Am; 2017 Sep; 46(3):481-492. PubMed ID: 28838410
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microbial Interactions and Interventions in Colorectal Cancer.
    Van Raay T; Allen-Vercoe E
    Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28643625
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy.
    Andrews MC; Reuben A; Gopalakrishnan V; Wargo JA
    Front Immunol; 2018; 9():946. PubMed ID: 29780391
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The bidirectional interaction of the gut microbiome and the innate immune system: Implications for chemotherapy-induced gastrointestinal toxicity.
    Secombe KR; Coller JK; Gibson RJ; Wardill HR; Bowen JM
    Int J Cancer; 2019 May; 144(10):2365-2376. PubMed ID: 30155890
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.
    Kumari R; Palaniyandi S; Hildebrandt GC
    Dig Dis Sci; 2019 Mar; 64(3):669-677. PubMed ID: 30523482
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition.
    Putignani L; Del Chierico F; Vernocchi P; Cicala M; Cucchiara S; Dallapiccola B;
    Inflamm Bowel Dis; 2016 Feb; 22(2):487-504. PubMed ID: 26588090
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Gut Microbiome in Inflammatory Bowel Disease: Lessons Learned From Other Immune-Mediated Inflammatory Diseases.
    Knox NC; Forbes JD; Peterson CL; Van Domselaar G; Bernstein CN
    Am J Gastroenterol; 2019 Jul; 114(7):1051-1070. PubMed ID: 31232832
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
    Qiao YQ; Cai CW; Ran ZH
    J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study.
    Azad MB; Konya T; Persaud RR; Guttman DS; Chari RS; Field CJ; Sears MR; Mandhane PJ; Turvey SE; Subbarao P; Becker AB; Scott JA; Kozyrskyj AL;
    BJOG; 2016 May; 123(6):983-93. PubMed ID: 26412384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microbiome-immune-metabolic axis in the epidemic of childhood obesity: Evidence and opportunities.
    Kincaid HJ; Nagpal R; Yadav H
    Obes Rev; 2020 Feb; 21(2):e12963. PubMed ID: 31663251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The potential impact of gut microbiota on your health:Current status and future challenges.
    Sirisinha S
    Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.
    Haak BW; Prescott HC; Wiersinga WJ
    Front Immunol; 2018; 9():2042. PubMed ID: 30250472
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antimicrobial Emulsifier-Glycerol Monolaurate Induces Metabolic Syndrome, Gut Microbiota Dysbiosis, and Systemic Low-Grade Inflammation in Low-Fat Diet Fed Mice.
    Jiang Z; Zhao M; Zhang H; Li Y; Liu M; Feng F
    Mol Nutr Food Res; 2018 Feb; 62(3):. PubMed ID: 29131494
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The gut microbiome in human immunodeficiency virus infection.
    Zilberman-Schapira G; Zmora N; Itav S; Bashiardes S; Elinav H; Elinav E
    BMC Med; 2016 Jun; 14(1):83. PubMed ID: 27256449
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gut microbiome and cancer immunotherapy.
    Li W; Deng Y; Chu Q; Zhang P
    Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction between gut microbiota and ethnomedicine constituents.
    Wu XM; Tan RX
    Nat Prod Rep; 2019 May; 36(5):788-809. PubMed ID: 30534698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.